课题基金 / 基金详情

基于cPLA2/5-LO/LTs通路研究薯蓣皂苷调控LTs代谢合成及其受体功能治疗类风湿性关节炎的作用及机制

批准号:
82060661
项目类别:
地区科学基金项目
资助金额:
33.0 万元
负责人:
杨树龙
依托单位:
学科分类:
抗炎与免疫药物药理
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
杨树龙

项目摘要

结项摘要

杨树龙的其他基金

相似基金

相关文献

中文摘要
类风湿性关节炎(RA)是以关节滑膜异常增生为主要特征的自身免疫性疾病,其发病机制未明。白三烯(LTs:LTB4和CysLTs)由花生四烯酸代谢生成,其合成酶系(cPLA2、5-LO、LTA4H或LTC4S)和/或受体功能改变导致LTs异常增加及其受体功能障碍是启动RA发病的重要机制。最近我们首次发现薯蓣皂苷保护RA模型小鼠可能涉及其抑制LTB4生成。本项目拟增加原代培养RA病人滑膜成纤维细胞离体模型,系统性地研究RA期间:LTs异常增加与其合成酶系、受体亲和力及功能变化相关性;薯蓣皂苷抑制LTB4异常增加与其对LTB4合成酶系、BLT1/2受体亲和力及功能变化影响的相关性;薯蓣皂苷对CysLTs异常增加的作用与其对CysLTs合成酶系、CYSLT1/2受体亲和力及功能变化影响的相关性。阐释薯蓣皂苷调控LTs代谢合成及其受体功能治疗RA的作用及机制,为临床治疗此顽疾提供新靶点和实验理论依据。
英文摘要
Rheumatoid arthritis(RA) is a common autoimmune disease. Pathological changes are chronic synovial membrane inflammation or proliferation and joint erosion. At present, the exact pathogenesis of RA has not been described and its treatment is always difficult. .5-Lipoxygenase(5-LO) catalyzes leukotriene(LTs) biosynthesis. After cell stimulation 5-LO translocates to the nuclear membrane, where it colocalizes with FLAP and the cytosolic phospholipase A2 (cPLA2) which releases arachidonic acid (AA) from the membrane. AA is oxidized into 5-hydroperoxyeicosatetraenoic acid which is converted into the instable epoxide leukotriene A4(LTA4). LTA4 can be either metabolized to LTB4 by LTA4 hydrolase or by LTC4 synthase into the cysteinyl-leukotriene LTC4 which is then further degraded to LTD4 and LTE4. LTs synthesis enzymes and/or receptor dysfunction can lead to clinical signs and symptoms of RA. .Growing evidence indicates that LTs play a pivotal role in RA pathogenesis. As a potent chemotactic mediator, LTB4 can provoke most signs and symptoms in RA by initiating, coordinating, sustaining, and amplifying the inflammatory response, through recruitment of leukocytes. It is highly present in synovial fluid and serum of patients with active RA. LTB4 enhances the neutrophil-dependent increased microvascular permeability and exerts its activity by coupling to BLT1 and BLT2. CysLTs exhibit several biological activities through at least two specific CysLT1 and CysLT2. Koshihara et al demonstrated that CysLTs were detected in synovial fluid in RA patients. Xu et al discovered CysLTs signaling pathway play a vital role in the pathogenesis of collagen-induced arthritis (CIA) mouse. Despite the progresses, so far seldom systemic and integrated studies have been employed to explore why the abnormal increased LTs of AA metabolites presented in synovial fluid and serum of patients with active RA. LTs receptor dysfunction in RA pathogenesis is not fully clear..LTs are responsible for the progressive destruction of cartilage and bones, neither steroids, nor the non steroidal anti-inflammatory drugs, cannot slow down cartilage and bone destruction providing only symptomatic improvement. Long-term use of therapies for RA produces adverse effects; hence there is a need for safe and effective alternatives suitable for long term chronic use. Dioscin is a kind of important steroidal saponins which is the important raw material for synthesis of steroid hormone drugs. It has been reported for the treatment of CIA animal, however, the mechanism underlying its treating RA is far from fully elucidated. Recently, we firstly found that the protective effects of dioscornin tablets on CIA mouse may involve in its inhibiting LTB4 generation. Here, using several agonists and/or antagonists of these synthases/receptor in LTs pathway, we will conduct some experiments such as in vivo CIA mice and in vitro model of primary cultured synovial fibroblasts of RA patients to focus on elucidating the following topics: 1. explore systematically the correlations between the abnormal increased LTs and the alterations of cPLA2, 5-LO, LTA4H or LTC4S gene and protein expressions, distributions and activities together with the alteration of LTs receptor affinity and its pathways; 2.whether the effects of dioscin inhibiting LTB4 generation involved in its influences on the gene and protein expressions, distributions and activities of cPLA2, 5-LO, LTA4H, as well as on the alteration of BLT1/2 affinity and its pathway; 3. whether the dioscin actions on abnormal increased CysLTs involved in its influences on the gene and protein expressions, distributions and activities of cPLA2, 5-LO, LTC4S, as well as on the alteration of CYSLT1/2 affinity and its function. These works if completed will further clarify the pathogenesis of RA and the protective mechanism dioscin against RA. It will provide new ideas and targets for traditional Chinese medicine to clinically prevent and treat RA disease.
类风湿关节炎(Rheumatoid arthritis, RA)是一种以关节滑膜异常增生为主要特征的自身免疫疾病。其发病机制未明。白三烯(LTs:LTB4和CysLTs)由花生四烯酸代谢生成,其合成酶系(cPLA2、5-LO、LTA4H或LTC4S)和/或受体功能改变导致LTs异常增加及其受体功能障碍是启动RA发病的重要机制。薯蓣皂苷具有调节免疫、抗炎、抗肿瘤、改善心血管功等多种药理作用。最近我们首次发现薯蓣皂苷保护RA模型小鼠可能涉及其抑制LTB4生成.。本项目拟应用CIA小鼠模型, TNF-α体外诱导FLS细胞作为RA的离体模型,以及原代培养RA病人滑膜成纤维细胞离体模型,阐释薯蓣皂苷调控LTs代谢合成及其受体功能治疗RA的作用及机制,为临床治疗此顽疾提供新靶点和实验理论依据。结果发现:1).低、中和高剂量Dio与TNF-α诱导的RAFLS细胞共同孵育24h,能显著抑制的增殖,提示其对TNF-α引起的RAFLS损伤具有保护作用。2)Dio可以降低TNF-α诱导的RAFLS细胞培养上清中LTB4的含量,这可能与其对FLS损伤的保护作用有关。3)Dio可能通过下调TNF-α诱导的RAFLS细胞中LTB4合成酶系5-LO和LTA4H表达,降低TNF-α诱导的RAFLS细胞培养上清中LTB4的含量。4)Dio可以降低TNF-α诱导的RAFLS细胞LTB4受体BLT1和BLT2的表达,阻碍LTB4下游通路,发挥对TNF-α诱导的RAFLS细胞损伤的治疗作用。5)低、中和高剂量组DT可明显降低CIA小鼠体重、关节指数、关节肿胀度以及胸腺指数、脾脏指数,并且可明显改善小鼠胸腺和脾脏病理损伤,因此对CIA小鼠有治疗作用。6)CIA模型组小鼠血清中LTB4的含量明显升高,不同剂量组DT均可显著降低CIA小鼠血清中LTB4的含量,表明LTB4异常增加可能与RA发病有关,而DT对CIA小鼠的治疗作用可能涉及其对LTB4含量的降低。7)DT通过降低CIA小鼠LTB4合成酶系5-LO和LTA4H的表达降低CIA小鼠血清中LTB4的含量。8)DT可以通过降低CIA小鼠脾脏中LTB4受体BLT1和BLT2的表达,阻碍LTB4发挥作用。9)采用TNF-α诱导的MH7A细胞作为RA细胞模型也发现同样的结果。为临床防治TAO这一顽症重疾提供新思路、新靶点和新途径。具有重要的理论意义和临床应用价值。
基于神经血管单元研究参附注射液抑制eNOS解耦增加NO生物利用度抗血管性痴呆的机制
  • 批准号:
    82360880
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    杨树龙
  • 依托单位:
基于COX信号通路探索参附注射液调控TXA2/PGI2平衡防治血栓闭塞性脉管炎的分子机制
  • 批准号:
    81660751
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    40.0万元
  • 批准年份:
    2016
  • 负责人:
    杨树龙
  • 依托单位:
硝普钠经5-LO/LTC4S途径抑制肝缺血再灌注早期LTC4异常增加的机制研究
  • 批准号:
    81260504
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    47.0万元
  • 批准年份:
    2012
  • 负责人:
    杨树龙
  • 依托单位:
国内基金
海外基金